|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.17 USD | -2.50% |
|
-1.68% | -80.00% |
| 05-14 | Maxim Downgrades Augmedix to Hold From Buy | MT |
| 05-14 | B. Riley Adjusts Price Target on Augmedix to $3 From $5.50, Keeps Buy Rating | MT |
Augmedix, Inc. provided revenue guidance for the year 2023. The company now expects approximately $44.5 million of revenue in 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -80.00% | 57.03M | |
| +16.45% | 71.21B | |
| +6.22% | 17.26B | |
| +13.63% | 13.96B | |
| +21.38% | 13.54B | |
| +16.25% | 10.13B | |
| -18.78% | 7.05B | |
| -1.24% | 6.17B | |
| +2.30% | 5.22B | |
| +1.00% | 5.06B |
AUGMEDIX, INC. 
